Rituximab is a chimeric monoclonal antibody specific for CD20.

Bavituximab is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections.

Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.

Ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.

The chimeric antibodies have at least two important attractions, she said.

Vapaliximab is a chimeric monoclonal antibody and an immunosuppressive drug.

Broken down into ab-ci-xi-mab, its name shows the drug to be a chimeric monoclonal antibody used on the cardiovascular system.

In one study, the chimeric antibodies showed a significantly lower tendency to cause allergic responses.

Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.

This was initially achieved by the production of chimeric and humanized antibodies.